Progress in molecular mechanism and targeted drugs of bone metastases in breast cancer
Breast cancer is the most common malignant tumor that threatens the health of women around the world, and bone is the site most prone to metastasis. The molecular mechanism concerned and targeted therapy against bone metastasis of breast cancer have become the current research hotspots. This article...
Main Author: | ZHENG Ya-nan, LI Mei, ZHAO Ji-yuan |
---|---|
Format: | Article |
Language: | zho |
Published: |
Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
2021-03-01
|
Series: | Jichu yixue yu linchuang |
Subjects: | |
Online Access: | http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/a200406.pdf |
Similar Items
-
Knockdown of AKT3 Activates HER2 and DDR Kinases in Bone-Seeking Breast Cancer Cells, Promotes Metastasis In Vivo and Attenuates the TGFβ/CTGF Axis
by: Nico Hinz, et al.
Published: (2021-02-01) -
The impacts of exosomes on bone metastatic progression and their potential clinical utility
by: Jenna Ollodart, et al.
Published: (2022-12-01) -
The relationship between the Hippo signaling pathway and bone metastasis of breast cancer
by: Qinyu Han, et al.
Published: (2023-05-01) -
The emerging role of osteoclasts in the treatment of bone metastases: rationale and recent clinical evidence
by: Youjun Liu, et al.
Published: (2024-08-01) -
Percutaneous CT-Guided Bone Lesion Biopsy for Confirmation of Bone Metastases in Patients with Breast Cancer
by: Lucija Kovacevic, et al.
Published: (2022-08-01)